Navigation Links
Annals of Internal Medicine tip sheet for May 20, 2008, issue
Date:5/19/2008

1. Sequential Therapy Appears Superior to Standard Therapy for Eradicating H. pylori

An evaluation of all randomized, controlled trials comparing sequential and standard triple therapies in patients with documented, previously untreated H. pylori infection found that sequential therapy appears superior to standard triple therapy for eradication of H. pylori infection.

Authors say if further trials confirm these findings, 10-day sequential therapy could become a standard treatment for H. pylori infection in patients who have not received treatment.

(NOTE: This article and editorial is being released early online at www.annals.org. It will appear in the June 17, 2008, print edition of the journal.)


2. Study Finds Physicians Often Do Not Adjust Medications When They Are Uncertain If an Elevated Blood Pressure Reading Is Correct

Editorial writers offer two paradigms for treatment. (Article, p. 717; Editorial, p. 783.)


3. Study Finds HIV-Infected People Have a Higher Risk of Some Common Cancers

A new study compared the incidence of different types of cancer among HIV-infected people with the incidence in the general population in the United States between 1992 and 2003 and found that certain cancers were more frequent among HIV-infected patients than among the general population (p. 728).

Besides cancers that are common with AIDS, these included vaginal, liver, lung, mouth or throat, colon, and kidney cancer, leukemia, and melanoma. Authors say that patients with HIV infection and their doctors should be alert for signs of these types of cancer.


4. Subclinical Thyroid Disease May Be Associated with a Modest Risk for Heart Disease

(NOTE: This article is being released early online at www.annals.org. It will appear in the June 3, 2008, print edition of the journal.)


'/>"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
Source:Eurekalert

Page: 1

Related medicine news :

1. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
2. September/October 2007 Annals of Family Medicine tip sheet
3. Annals of Internal Medicine tip sheet for Oct. 2
4. Annals of Internal Medicine Tip Sheet for Nov. 20, 2007, Issue
5. Annals of Internal Medicine tip sheet for Jan. 1, 2008, issue
6. Annals of Internal Medicine tip sheet for Feb. 5, 2008, issue
7. Annals of Internal Medicine tip sheet for April 1, 2008, issue
8. Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
9. May/June 2008 Annals of Family Medicine tip sheet
10. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
11. Internal medicine physicians recommend key elements to guide state initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Breaking Medicine Technology:Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 2The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 3The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 4The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 5The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 6The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 7The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 8The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 9The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 10The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 11The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 12The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 13Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 1Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 2Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 3Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 4Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 5Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 6Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 7Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 8Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 9Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 10Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 11Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 12Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 13Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 14Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 15Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 16Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 17Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 18Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 19Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 20Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 21Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 22